Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell, Metastatic Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT02626130
What this trial is testing

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01158222
What this trial is testing

Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 37
Early research (Phase 1)Ended earlyNCT03260504
What this trial is testing

Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+1 more
University of Washington 6
Testing effectiveness (Phase 2)Study completedNCT00182702
What this trial is testing

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)WithdrawnNCT04603365
What this trial is testing

Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer

Who this might be right for
Clear Cell Papillary Renal NeoplasmCollecting Duct CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+8 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT07084909
What this trial is testing

Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Lantheus Medical Imaging
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035224
What this trial is testing

Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 28
Early research (Phase 1)Not Yet RecruitingNCT05698238
What this trial is testing

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more
Mabpro, a.s. 50
Testing effectiveness (Phase 2)Ended earlyNCT01216371
What this trial is testing

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

Who this might be right for
Renal Cell CarcinomaPulmonary Metastases
Association of Urologic Oncology (AUO) 60
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Testing effectiveness (Phase 2)Looking for participantsNCT07188896
What this trial is testing

Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)Metastatic Renal Cell Carcinoma ( mRCC)Clear Cell Renal Cell Carcinoma (ccRCC)
Brian Rini 120
Post-approval studies (Phase 4)Study completedNCT00006864
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)WithdrawnNCT00293527
What this trial is testing

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

Who this might be right for
Renal Cancer
Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07197580
What this trial is testing

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Testing effectiveness (Phase 2)Looking for participantsNCT05263050
What this trial is testing

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaClear-cell Metastatic Renal Cell CarcinomaNeuroendocrine Tumors+1 more
Fox Chase Cancer Center 111
Not applicableStudy completedNCT02848768
What this trial is testing

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Rennes University Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Testing effectiveness (Phase 2)Study completedNCT00331409
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 23
Large-scale testing (Phase 3)Looking for participantsNCT04510597
What this trial is testing

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
SWOG Cancer Research Network 364
Next Page